Metraipolis › archive › dc_245abf0d641b

Integrating new and "old" cellular therapies in the evolving landscape of relapsed or refractory large B-cell lymphoma — Europe PMC PMID:42807827

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42807827
DOI
10.3389/fonc.2026.1924365
License (as archived)
solo-consultazione
Archived
2026-10-10T02:32:04.679Z
SHA-256 of the archived text
fc3fcda32c1490d69da370d819dc565b3070eea3d5fca1f278b39212afb30e80
Stable URL of this page
https://metraipolis.com/documento/dc_245abf0d641b

How to cite

Integrating new and "old" cellular therapies in the evolving landscape of relapsed or refractory large B-cell lymphoma — Europe PMC PMID:42807827 — Europe PMC (en), https://europepmc.org/article/MED/42807827 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_245abf0d641b (Metraipolis archive dc_245abf0d641b, sha256 fc3fcda32c1490d69da370d819dc565b3070eea3d5fca1f278b39212afb30e80)
BibTeX
@misc{dc245abf0d641b,
  title = {Integrating new and "old" cellular therapies in the evolving landscape of relapsed or refractory large B-cell lymphoma — Europe PMC PMID:42807827},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42807827},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_245abf0d641b; sha256 fc3fcda32c1490d69da370d819dc565b3070eea3d5fca1f278b39212afb30e80},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42807827. Agents can read the archived copy with the MCP tool read_document.